(function(doc, html, url) { var widget = doc.createElement("div"); widget.innerHTML = html; var script = doc.currentScript; // e = a.currentScript; if (!script) { var scripts = doc.scripts; for (var i = 0; i < scripts.length; ++i) { script = scripts[i]; if (script.src && script.src.indexOf(url) != -1) break; } } script.parentElement.replaceChild(widget, script); }(document, '

Challenges Faced by Women Recommended Anti-Hormonal Medication: 50% Maintain Intake for 5 Years

What is it about?

Anti-hormonal medication is intended to prevent breast cancer recurrence. For half of the women who are recommended to take anti-hormonal medication after the initial treatment for breast cancer has ended, it can be challenging to continue the treatment for five years. The latest findings do not show any improvement in the adherence rate. Findings are based on the National Dutch Cancer Registry and the PHARMO data base.

Why is it important?

Health care provider should know that adherence to anti-hormonal medication might be low. As the literature indicates, the topic is often not discussed, which implies that potential solutions are not explored.

Read more on Kudos…
The following have contributed to this page:
Ilse Mesters
' ,"url"));